Results 171 to 180 of about 3,233,658 (249)
[A&T]MLN is a triple‐modal nanoplatform with siRNA‐loaded LN coated with hybrid ACE2/macrophage membrane. It blocks viral entry, neutralizes IL‐6/IL‐1β/TNF‐α, and delivers siRNA to suppress viral replication. In a murine lung injury model, it attenuates inflammation, offering a multi‐pronged strategy against SARS‐CoV‐2 variants and hyperinflammation ...
Hui Li +19 more
wiley +1 more source
CT-Guided Lipid-Lowering Therapy Leading to Functional Resolution of Ischemia. [PDF]
Kołtowski Ł +9 more
europepmc +1 more source
Intelligent Programmable Membrane Nanosponge for Early Virus Blocking
A smart programmable nanosponge (ACNPs) displays high‐density viral receptors on its membrane and encapsulates fusion inhibitors to capture virions at the infection source through competitive binding and blocks their entry through protease inhibition for ultra‐early cascade interception. This modular, mucus‐penetrating platform shifts antiviral defence
Ze Chen +17 more
wiley +1 more source
Lipid-lowering therapy in Switzerland: time trends in utilization and cost, 2015-2023. [PDF]
Wolf S +4 more
europepmc +1 more source
A bidirectional calcium‑redistributing nanomodulator rewires intra‑extracellular calcium homeostasis to remodel tumor mechanical microenvironments. It softens tumor stroma to facilitate deep tissue penetration while stiffening tumor cells, evoking amplified immunogenic cell death and robust CTL infiltration, which achieves potent deep photothermal ...
Hongjuan Zhao +9 more
wiley +1 more source
Improving adherence to guideline-based lipid-lowering therapy in people with hyperlipidemia using a targeted educational outreach approach. [PDF]
Conley E +8 more
europepmc +1 more source
We use lysine‐to‐glutamine mutations to study the effect of electrostatics on the kinetics and thermodynamics of alpha‐synuclein amyloid fibril formation. We find that mutational effects map on their structural context within fibrils and identify residues that modulate the energy landscape of alpha‐synuclein self‐assembly. Our work outlines a scalable,
Antonin Kunka +10 more
wiley +1 more source
Acute Coronary Syndrome With Persistent Thin-Cap Fibroatheroma Despite Intensive Lipid-Lowering Therapy: Insights From Serial Optical Coherence Tomography. [PDF]
Miura M +5 more
europepmc +1 more source
A carrier‐free zinc‐coordinated polyphenol nanoplatform (ZnCA NPs) is designed as an “all‐in‐one” therapeutic strategy for intestinal inflammation. The ZnCA NPs exhibit enhanced colonic accumulation and broad‐spectrum reactive oxygen and nitrogen species scavenging.
Qiwen Xie +7 more
wiley +1 more source
Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review. [PDF]
Stephan D, Zamperini C, Cordeanu EM.
europepmc +1 more source

